Clint T Allen

Associate Professor

20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Clint T Allen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Open Access
  • Inhibition of MDSC trafficking with SX-682, a CXCR1/2 inhibitor, enhances NK-cell immunotherapy in head and neck cancer models

    Greene, S., Robbins, Y., Mydlarz, W. K., Huynh, A. P., Schmitt, N. C., Friedman, J., Horn, L. A., Palena, C., Schlom, J., Maeda, D. Y., Zebala, J. A., Clavijo, P. E. & Allen, C., Mar 15 2020, In : Clinical Cancer Research. 26, 6, p. 1420-1431 12 p.

    Research output: Contribution to journalArticle

  • Mechanisms of resistance to T cell-based immunotherapy in head and neck cancer

    Lee, M. Y. & Allen, C. T., Jan 1 2020, (Accepted/In press) In : Head and Neck.

    Research output: Contribution to journalReview article

  • Neoadjuvant PD-1 immune checkpoint blockade reverses functional immunodominance among tumor antigen–specific T cells

    Friedman, J., Moore, E. C., Zolkind, P., Robbins, Y., Clavijo, P. E., Sun, L., Greene, S., Morisada, M. V., Mydlarz, W. K., Schmitt, N., Hodge, J. W., Schreiber, H., van Waes, C., Uppaluri, R. & Allen, C., Feb 1 2020, In : Clinical Cancer Research. 26, 3, p. 679-689 11 p.

    Research output: Contribution to journalArticle

  • PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations

    Fabian, K. P., Padget, M. R., Donahue, R. N., Solocinski, K., Robbins, Y., Allen, C. T., Lee, J. H., Rabizadeh, S., Soon-Shiong, P., Schlom, J. & Hodge, J. W., May 20 2020, In : Journal for immunotherapy of cancer. 8, 1, e000450.

    Research output: Contribution to journalArticle

    Open Access